Medicija has acquired Kretingos Šeimos Medicinos Centras
January 2026 — Medicija has acquired Kretingos Šeimos Medicinos Centras, a primary healthcare services provider based in Kretinga, Lithuania. The acquisition strengthens Medicija’s position in Western Lithuania and supports greater vertical integration between primary healthcare and specialist medical services. It supports the company’s strategy to build a leading full-service healthcare group with a strong presence across Lithuania’s major cities.
Medicija is a private healthcare services provider focused on fertility, specialist and primary healthcare services, with operations in Vilnius, Kaunas and Klaipėda.
Established in 2000 by three medical doctors, Kretingos Šeimos Medicinos Centras is the largest private primary healthcare provider in the city of Kretinga, employing nearly 30 people and serving approximately 9,000 registered patients.
Our role in the transaction
Oaklins’ team in Lithuania acted as the exclusive buy-side advisor to Medicija.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more